Walmart Closes Health and Virtual Care Centers
Company officials said a challenging reimbursement environment and escalating operating costs created a lack of profitability for the business.
Walmart has made the decision to close all of its 51 health centers and virtual care programs across five states, the company announced this morning. Walmart officials said a challenging reimbursement environment and escalating operating costs create a lack of profitability.
“Through our experience managing Walmart Health centers and Walmart Health Virtual Care, we determined there is not a sustainable business model for us to continue,” officials said in a statement.
The statement indicated that Walmart will continue to offer immunizations and provide Testing and Treatment services through its pharmacies, access to specialty pharmacy medication and care, as well as other essential services such as medication therapy management and a variety of health screenings.
No date has been announced for the closing of the centers. Provider partners will continue to see patients while clinics are open. Through their respective employers, these providers will be paid for 90 days.
Walmart Health launched in 2019. As of November 2023, Walmart was still expanding the health centers, when it announced relationships in Florida with Ambetter from Sunshine Health and with Orlando Health. Ambetter Sunshine Health provides insurance to individuals through the Florida health insurance marketplace. Orlando Health is private, not-for-profit network of community and specialty hospitals across Florida.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
July 2nd 2025FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine release syndrome and neurological toxicities.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
